Browse > Article

Evaluation of the Anti-inflammatory and Immunomodulatory Effects of BSASM Using in vitro Experiments  

Lee, Jong-Sung (Biospectrum Life Science Institute)
Park, Yu-Mi (Biospectrum Life Science Institute)
Park, Byung-Hwa (Biospectrum Life Science Institute)
Jung, Kwang-Seon (Biospectrum Life Science Institute)
Kim, Kuk-Hyun (Biospectrum Life Science Institute)
Lee, Won-Hee (Greencross R&D)
Park, Deok-Hoon (Biospectrum Life Science Institute)
Publication Information
Korean Journal of Pharmacognosy / v.34, no.3, 2003 , pp. 228-232 More about this Journal
Abstract
For effective management of atopic dermatitis, it is important to introduce a therapeutic agent although having the fewest side effects, has the greatest anti- inflammatory effect. In the course of screening anti-inflammatory agents, we obtained BSASM composed of several plant extracts. This study was designed to investigate anti-inflammatory and immunomodulatory effects of BSASM. As a first step, $NF-{\kappa}B$ luciferase reporter assay was performed to know the involvement of BSASM in the production of proinflammatory cytokines because $NF-{\kappa}B$ element has been known to play a major role in expression of cytokine genes such as interleukin-8 (IL-8) or tumor necrosis $factor-{\alpha}\;(TNF-{\alpha})$. LPS (lipolysaccharide)-induced $NF-{\kappa}B$ activation was inhibited by BSASM. In addition, we found the fact that BSASM inhibits LPS-induced produced production of IL-8 and $TNF-{\alpha}$ proinflammatory cytokines, indicating BSASM has anti-inflammatory effect. In interleukin-2 (IL-2) luciferase reporter assay in Jurkat T cells, BSASM reduced PHA (Phytohemagglutinin)-induced IL-2 luciferase activity, suggesting the possibility that BSASM might also have an immunomodulatory function in T cell-mediated immune response. Based on these results, we suggest the possibility that BSASM can be introduced to improve symptom of immune-related skin diseases, namely, atopic dermatitis.
Keywords
Chronic dermatitis; anti-inflammatory effect; BSASM; IL-8; $TNF-{\alpha}$; IL-2;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cooper, K. D. (1994) Atopic dermatitis: recent trends in pathogenesis and therapy J. Invest. Dermatol. 102: 128-137   DOI   ScienceOn
2 Czech, W., Schopf, E., and Kapp, A. (1996) Soluble Eselectin in sera of patients with atopic dermatitis and psoriasis-correlation with disease activity. Br. J. Dermatol. 134: 17-21   DOI   ScienceOn
3 Zheng-Ming, W., Chao, L., and Roman Dziarski. (2000) Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 275(27): 20260-20267   DOI   ScienceOn
4 Anderson, S. J. and Perlmutter, R. M. (1995) A signaling pathway governing early thymocyte maturation. Immunol. Today 16: 99-105   DOI   ScienceOn
5 Minami, Y., Kono, T., Yamada, K., Kobayashi, N., Kawahara, A., Perlmutter, R. M., and Taniguchi, T. (1993) Association of p56lck with IL-2 receptor beta chain is critical for the IL-2induced activation of p56lck. EMBO J. 12: 759-768
6 Venge, P. (1993) Eosinophil and neutrophil granulocytes. Allergy. 36: 95-102
7 Tanaka, S., Yoichi, S., Ao, L., Matumoto, M., Morimoto, K., Akimoto, N., Honda, G., Tabata, M., Oshima, T.,Masuda, T., Asmawi, M. Z., Ismail, Z., Yusof, S. M., Din, L. B., and Said, I. M. (2001) Potential immunosuppressive and antiinflammatory activities of malaysian medicinal plants characterized by reduced cell surface expression of cell adhesion molecules. Phytother Res. 15(8): 681-686   DOI   ScienceOn
8 Molina, T. J., Kishihara, K., Siderovski, D. P, van Ewijk, W., Narendran, A., Timms, E., Wakeham, A., Paige, C. J., Hartmann, K. U., and Veillette, A. (1992) Profound block in thymocyte development in mice lacking p56lck. Nature 357: 161-164   DOI   ScienceOn
9 Naofumi, M., Shu-ichi, O., Yuji, I., and Kouji, M. (1994) Molecular mechanism of interleukin-8 gene expression. J. Leukocyte Biology 56: 554-558
10 Miescher, S. M. and Vogel, M. (2002) Molecular aspects of allergy. Mol. Aspects Med. 23(6): 413-462   DOI   ScienceOn
11 Young, B. C., Chan, K. K., and Yungdae, Y. (1999) An adapter protein interacting with the SH2 domain of p56lck , is required for T cell activation. J. Immunol. 163: 5242-5249
12 Jain, A. and Basal, E. (2003) Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine 10: 34-38   DOI   ScienceOn
13 Marth, J. D., Cooper, J. A., King, C. S., Ziegler, S. F., Tinker, D. A., Overell, R. W., Krebs, E. G., and Perlmutter, R. M. (1988) Neoplastic transformation induced by an activated 1lymphocyte-speciific protein tyrosne kinase (p56lck).mol. Cell. BioI. 8: 540-550
14 Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins., J. Immunol. 136: 2348-2357
15 Ackerman, S. J., Loegering, D. A., Venge, P., Olsson, I., Harley, J. B., and Fauci, A. S. (1983) Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin., J. Immunol. 131: 2977-2982
16 Li, M. Y., Ryan, P., and Batey, R. G. (2003) Traditional Chinese medicine prevents intlammation in $CCI_4$-related liver injury in mice. Am. J. Chin. Med. 31(1): 119-127   DOI   ScienceOn
17 Yuan, R. and Lin, Y. (2000) Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 86(2): 191-198   DOI   ScienceOn
18 Hatakeyama, M., Kono, T., Kobayashi, N., Kawahara, A, Levin, S. D., Perlmutter, R. M., and Taniguchi, T. (1991) Interaction of the IL-2 receptor with the src-family kinase p56lck : identification of novel intermolecular association. Science 252: 1523-1528   DOI   PUBMED
19 Benjamin, R. V., Shijun, Y., and James, J. L. (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes. Infection and Immunity. 63: 3158-3165
20 Robinson, N., Singri, P., and Gordon, K. M. (2001) Safety of the new macrolide immunomodulators. Semin Cutan Med Surg. 20(4): 242-249   DOI   ScienceOn
21 Jongsung, L., Byunghwa P, Kwangseon, 1., Kukhyun K., Kyu, H. K., and Deokhoon P. (2003) Evaluation of the antiintlanunatory and atopic dermatitis-mitigating effects of BSASM. Acta Derm Venereol. (submitted)
22 Vender, R. B. (2002) ltemative treatments for atopic dermatitis: A selected review. Skin Therapy Lett. 7(2): 1-5
23 Bos, J. D. Wierenga, O., Si1levis, J. H., Heijden, F. L., and Kapsenberg, M. L. (1992) Immune dysregulation in atopic eczema. Arch. Dermatol. 128: 1509-1512   DOI   ScienceOn
24 이성훈, 이주홍, 이승철, 김영근 (1998) 아토피 피부염 환자의 중증도 지표로서의 혈청 InterLeukin-4에 관한 연구. 대피지 36: 95-102
25 Li, M. Y., Ryan, P., and Batey, R. G. (2003) Traditional Chinese medicine prevents intlammation in $CC1_4$-related liver injury in mice. Am. J. Chin. Med. 31(1): 119-127   DOI   ScienceOn
26 Benjamin, R., Vowels, S. Y., and James, J. L. (1995) Induction of proinflammatory cytokines by. a soluble factor of Propionibacterium acnes: Implication for chronic inflammatory acne. Infection and Immunity 63(8): 3158-3165
27 Baumann, L., Kerdel, F. Freedberg, I. M., Eisen, A. Z., Wolff, K., Austin, K. F., Goldsmith, L. A., Katz, S. I., and Fitzpatrick, T. B. (1999) Dermatology in general medicine. (5th ed.), 2713-2717. Academic Press, New York, NY